This site may contain affiliate links. We may earn a commission at no cost to you. Learn more
Home Clinical Guides Clinical Decisions
Clinical Decisions

GLP-1 Drug Interactions: What to Tell Your Doctor

The medications that interact with GLP-1 therapy — and exactly what your doctor and pharmacist need to know.

GLP-1 medications work partly by slowing gastric emptying — how quickly food and other substances move through your stomach. This mechanism, while central to their effectiveness, creates a cascading effect on how your body absorbs other medications you take by mouth.

The result isn't always dangerous, but it's always worth knowing about. Some interactions require dose adjustments. Others require changes in timing. A few require you to stop one medication entirely. Here's the complete picture, organized by what matters most.

How GLP-1 Medications Affect Other Drugs

The primary interaction mechanism is delayed gastric emptying. When your stomach empties more slowly, oral medications spend more time sitting in your stomach acid before reaching the intestine where they're absorbed. This typically causes two pharmacokinetic changes:

Reduced peak concentration (Cmax) — the maximum amount of drug that reaches your bloodstream at any one time goes down. For medications that need to hit a certain threshold to work (like pain relievers), this means slower onset of action.

Delayed time to peak (Tmax) — it takes longer for the drug to reach its maximum level in your blood. For time-sensitive medications, this delay can matter clinically.

Importantly, the total amount of drug absorbed (AUC) often remains unchanged — you still absorb the full dose, it just takes longer. This distinction is critical: the interaction is usually about timing, not total absorption.

High-Priority Interactions

Insulin

High Priority

Both GLP-1 medications and insulin lower blood sugar, but through different mechanisms. GLP-1 agonists stimulate glucose-dependent insulin release (your body only releases insulin when blood sugar is elevated), while injected insulin works regardless of your glucose level. Together, the risk of hypoglycemia — dangerously low blood sugar — increases substantially.

Clinical protocol: Most clinicians reduce insulin doses by approximately 20% when initiating GLP-1 therapy in patients whose HbA1c is below 8.0%. Patients with HbA1c above 8.5% may maintain their insulin dose initially, with close glucose monitoring and a plan to taper as control improves. Never stop insulin abruptly — this requires careful medical supervision.

Sulfonylureas (Glipizide, Glyburide, Glimepiride)

High Priority

Sulfonylureas force your pancreas to release insulin regardless of your blood sugar level. This glucose-independent mechanism is fundamentally at odds with the "smart," glucose-dependent mechanism of GLP-1 medications, creating a high-risk environment for hypoglycemia.

Clinical protocol: The 2025 ADA Standards of Care support discontinuing sulfonylureas entirely when adding a GLP-1 agonist. If discontinuation isn't appropriate, the dose should be reduced by 50% for patients with HbA1c between 7.6% and 8.5%. For HbA1c below 7.5%, stopping the sulfonylurea is strongly preferred.

Oral Contraceptives (Birth Control Pills)

High Priority — Tirzepatide Only

This interaction depends on which GLP-1 medication you're taking, and the difference is clinically important.

Tirzepatide (Zepbound/Mounjaro): The prescribing information contains a specific warning that tirzepatide may decrease the effectiveness of hormonal oral contraceptives. The dual-agonist mechanism appears to alter gastric motility or drug absorption in a way that reduces birth control pill exposure during dose-escalation periods.

Semaglutide (Wegovy/Ozempic) and Liraglutide: Clinical studies indicate these medications do not significantly reduce oral contraceptive bioavailability. However, severe GI side effects (vomiting, diarrhea) can physically prevent absorption of any oral medication, requiring backup contraception during symptomatic periods.

Clinical protocol: For patients on tirzepatide — use a backup barrier method (condoms) or switch to a non-oral contraceptive (IUD, implant) for 4 weeks after starting therapy and for 4 weeks after each dose increase. For patients on semaglutide, no routine backup is required unless GI side effects are severe.

Thyroid Medications (Levothyroxine)

Moderate Priority

Levothyroxine has a notoriously narrow therapeutic window and strict absorption requirements. Counterintuitively, GLP-1 medications may actually increase thyroid hormone absorption — studies with oral semaglutide showed approximately 33% higher total thyroxine (T4) exposure, likely because the delayed gastric emptying gives levothyroxine more time to dissolve and absorb.

Clinical protocol: Continue taking levothyroxine on an empty stomach, 30–60 minutes before any food or other medication. If you're also taking oral semaglutide (Rybelsus), strict timing separation is critical — some clinicians recommend moving levothyroxine to bedtime (4 hours after your last meal) to avoid the conflict. TSH should be rechecked 6–8 weeks after starting GLP-1 therapy or after any dose change.

Warfarin (Blood Thinners)

Moderate Priority

Warfarin requires precise dosing to maintain your INR (International Normalized Ratio) within a target range. Delayed gastric emptying delays warfarin's absorption peak, and while the total amount absorbed may remain similar, the altered timing can destabilize INR control. Case reports have documented significant INR fluctuations — in both directions — when patients started tirzepatide while on warfarin.

Clinical protocol: Patients on warfarin need frequent INR monitoring during GLP-1 initiation and throughout dose titration. Expect potential volatility and plan for reactive warfarin dose adjustments. For patients on DOACs (apixaban, rivarexaban), the interaction is less critical but monitoring is still advised, especially with significant weight changes.

Moderate-Priority Interactions

Blood Pressure Medications

Moderate Priority

There's no direct pharmacokinetic interference between GLP-1 medications and most blood pressure drugs. However, the pharmacodynamic effect is substantial: as you lose weight, your blood pressure naturally drops. GLP-1 medications also promote sodium excretion (natriuresis), which further lowers blood pressure. The combination can lead to lightheadedness or fainting if your antihypertensive doses aren't adjusted downward.

Clinical protocol: Monitor blood pressure regularly at home. "Deprescribing" — reducing the dose of blood pressure medication — is commonly needed as patients lose weight. This is actually a positive outcome, but it requires active management rather than waiting for symptoms.

DPP-4 Inhibitors (Sitagliptin, Saxagliptin, Linagliptin)

Moderate Priority

DPP-4 inhibitors work by preventing the breakdown of your body's natural GLP-1. Taking them alongside an injected GLP-1 agonist is therapeutically redundant — you're already flooding the system with far more GLP-1 activity than the DPP-4 inhibitor could produce. The combination doesn't enhance effectiveness but does increase side effects.

Clinical protocol: Discontinue the DPP-4 inhibitor when starting GLP-1 therapy. This is a straightforward switch — no taper needed.

NSAIDs (Ibuprofen, Naproxen)

Moderate Priority

The concern here isn't about absorption — it's about kidney function. GLP-1 medications can cause volume depletion through vomiting, diarrhea, and natriuresis. NSAIDs constrict blood vessels in the kidneys. The combination, especially during dehydration episodes, can increase the risk of acute kidney injury.

Clinical protocol: Avoid chronic NSAID use while on GLP-1 therapy, particularly during periods of GI side effects. Occasional use for acute pain is generally safe when you're well-hydrated. If you need regular pain management, discuss alternatives with your doctor.

Lower-Priority (But Worth Knowing)

Acetaminophen (Tylenol)

Low Priority

GLP-1 medications consistently delay the absorption peak of acetaminophen. This means your headache relief may take longer to kick in — a comfort issue, not a safety one. The total amount absorbed remains unchanged.

SSRIs and SNRIs (Antidepressants)

Low Priority

Absorption may be delayed, but generally no dose adjustment is required. However, patients should be monitored for "breakthrough" symptoms — anxiety, mood changes, or depressive episodes — during GLP-1 titration phases, as steady-state concentrations might temporarily fluctuate.

Oral Antibiotics

Low Priority

For antibiotics that require rapid absorption to reach effective concentrations, the delay can theoretically reduce efficacy. If you're prescribed a short-course antibiotic while on GLP-1 therapy, discuss timing with your pharmacist — separating doses by at least one hour may help.

Metformin

Low Priority

Good news: metformin and GLP-1 medications are complementary, not conflicting. Their mechanisms of action don't overlap, and the combination is well-supported in clinical guidelines. No dose adjustment needed.

Quick Reference Table

DrugInteractionAction Required
InsulinHypoglycemia riskReduce dose ~20% at initiation
SulfonylureasHypoglycemia riskDiscontinue or reduce 50%
Birth control pillsReduced absorption (tirzepatide)Backup method for 4 weeks at start + each dose increase
LevothyroxineAltered absorptionStrict timing; recheck TSH at 6–8 weeks
WarfarinINR instabilityFrequent INR monitoring during titration
BP medicationsAdditive BP reductionMonitor; expect deprescribing
DPP-4 inhibitorsTherapeutic redundancyDiscontinue the DPP-4
NSAIDsKidney risk if dehydratedAvoid chronic use; hydrate
MetforminNone significantContinue as prescribed

Surgery and GLP-1 Medications

If you're scheduled for any procedure requiring anesthesia, your GLP-1 medication requires special consideration. Delayed gastric emptying means your stomach may still contain food even after standard fasting periods, increasing aspiration risk during anesthesia.

Current consensus guidelines recommend: if you're experiencing GI symptoms, delay elective surgery. If you're asymptomatic and taking a daily formulation, hold on the day of surgery. For weekly formulations, some anesthesiologists prefer holding one week prior — but this varies by institution. A liquid-only diet for 24 hours before surgery is recommended if you're continuing the medication.

Always tell your anesthesiologist and surgical team that you're on a GLP-1 medication — even if they don't ask.

Want a Full Medication Review?

Sesame Care connects you with board-certified clinicians who can review your full medication list and ensure your GLP-1 therapy is safe alongside everything else you take.

Book a Consultation at Sesame Care →

What to Bring to Your Next Appointment

Make your doctor's job easier (and your care safer) by bringing a complete, current list of everything you take — prescription medications, over-the-counter drugs, vitamins, and supplements. Don't forget to include dosages, frequency, and timing.

Pay special attention to any medications you've recently started, stopped, or changed doses on. And if you're seeing multiple providers (which is common — a PCP, an endocrinologist, a telehealth GLP-1 prescriber), make sure each one has the same, current information. Fragmented care is where drug interactions fall through the cracks.